I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Mpoudi-Etame, Mireille
31
results:
Search for persons
X
Format
Online (31)
Mediatypes
Articles (Online) (11)
OpenAccess-fulltext (20)
Languages
french (1)
english (26)
Sorted by: Relevance
Sorted by: Year
?
1
Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:
Tovar Sanchez, Tamara
;
Mpoudi-Etame, Mireille
;
Kouanfack, Charles
...
Frontiers in Reproductive Health. 5 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
2
Durability of the Efficacy and Safety of Dolutegravir-Based..:
Mpoudi-Etame, Mireille
;
Tovar Sanchez, Tamara
;
Bousmah, Marwân-al-Qays
...
Open Forum Infectious Diseases. 10 (2023) 12 - p. , 2023
Link:
https://doi.org/10.1093/..
?
3
Rapid Increase of Community SARS-CoV-2 Seroprevalence durin..:
Ndongo, Francis Ateba
;
Guichet, Emilande
;
Mimbé, Eric Donald
...
Emerging Infectious Diseases. 28 (2022) 6 - p. , 2022
Link:
https://doi.org/10.3201/..
?
4
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:
For The New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group
;
Bousmah, Marwân-al-Qays
;
Nishimwe, Marie Libérée
...
PharmacoEconomics. 39 (2020) 3 - p. 331-343 , 2020
Link:
https://doi.org/10.1007/..
?
5
Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:
Tovar Sanchez, Tamara
;
Mpoudi-Etame, Mireille
;
Kouanfack, Charles
...
http://eprints.lse.ac.uk/120539/1/frph_05_1133556.pdf. , 2023
Link:
http://eprints.lse.ac.uk..
?
6
Durability of the Efficacy and Safety of Dolutegravir-Based..:
Mpoudi-Etame, Mireille
;
Tovar Sanchez, Tamara
;
Bousmah, Marwân-al-Qays
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754645/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
Risks of metabolic syndrome in the ADVANCE and NAMSAL trial:
Tovar Sanchez, Tamara
;
Mpoudi-Etame, Mireille
;
Kouanfack, Charles
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544962/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:
Bousmah, Marwân-Al-Qays
;
Nishimwe, Marie, Libérée
;
Tovar-Sanchez, Tamara
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021
Link:
https://hal.umontpellier..
?
9
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:
Bousmah, Marwân-Al-Qays
;
Nishimwe, Marie, Libérée
;
Tovar-Sanchez, Tamara
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021
Link:
https://hal.umontpellier..
?
10
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:
Bousmah, Marwân-Al-Qays
;
Nishimwe, Marie, Libérée
;
Tovar-Sanchez, Tamara
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021
Link:
https://hal.umontpellier..
?
11
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:
Bousmah, Marwân-Al-Qays
;
Nishimwe, Marie, Libérée
;
Tovar-Sanchez, Tamara
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021
Link:
https://hal.umontpellier..
?
12
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Do..:
BOUSMAH, Marwân-al-Qays
;
Nishimwe, Marie
;
Tovar-Sanchez, Tamara
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s40273-020-00987-3. , 2021
Link:
https://hal.umontpellier..
?
13
Cost-Effectiveness of Three Alternative Boosted Protease In..:
Boyer, S
;
Nishimwe, M. L
;
Sagaon-Teyssier, Luis
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s41669-019-0157-9. , 2020
Link:
https://hal.archives-ouv..
?
14
Cost-Effectiveness of Three Alternative Boosted Protease In..:
Boyer, S
;
Nishimwe, M. L
;
Sagaon-Teyssier, Luis
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s41669-019-0157-9. , 2020
Link:
https://hal.science/hal-..
?
15
Cost-Effectiveness of Three Alternative Boosted Protease In..:
Boyer, S
;
Nishimwe, M. L
;
Sagaon-Teyssier, Luis
...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s41669-019-0157-9. , 2020
Link:
https://hal.science/hal-..
1-15
